JCI - Citations to Progress on new vaccine strategies for the immunotherapy and prevention of cancer

Citations to this article

Progress on new vaccine strategies for the immunotherapy and prevention of cancer

Jay A. Berzofsky, … , John E. Janik, John C. Morris

Jay A. Berzofsky, … , John E. Janik, John C. Morris

Published June 1, 2004
Citation Information: J Clin Invest. 2004;113(11):1515-1525. https://doi.org/10.1172/JCI21926.

View: Text | PDF

Total citations by year

Year:	2025	2024	2023	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	Total
Citations:	3	3	1	1	2	1	3	2	3	3	4	2	6	5	7	6	4	5	9	2	72

Citation information

Citations to this article (72)

Title and authors	Publication	Year
Dendritic Cell Cancer Vaccines: A Focused Review. Maeng HM, Olkhanud PB, Black M, Highfill SL, Stroncek DF, Berzofsky JA	Methods in molecular biology (Clifton, N.J.)	2025
Current Landscape of Therapeutic Cancer Vaccines. Rosenthal I, Padler-Karavani V	Methods in molecular biology (Clifton, N.J.)	2025
Clinical Applications of the Molecular Landscape of Melanoma: Integration of Research into Diagnostic and Therapeutic Strategies Szabó IL, Emri G, Ladányi A, Tímár J	Cancers	2025
Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases Kurilin V, Alshevskaya A, Sennikov S	Biomedicines	2024
Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies. Ali K, Nabeel M, Mohsin F, Iqtedar M, Islam M, Rasool MF, Hashmi FK, Hussain SA, Saeed H	Medical Oncology	2024
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy. Kumari K, Singh A, Chaudhary A, Singh RK, Shanker A, Kumar V, Haque R	Human vaccines	2024
The Apoptotic Potential Activity of Terminalia Brownii Extracts against Various Cancer Cell Lines. Alfaifi MY, Alqasem ZA	Asian Pacific Journal of Cancer Prevention	2023
Antigen-loaded monocyte administration induces potent therapeutic anti-tumor T cell responses Min-Nung Huang, Lowell T Nicholson, Kristen Batich, Adam M Swartz, David Kopin, Sebastian Wellford, Vijay K. Prabhakar, Karolina Woroniecka, Smita Nair, Peter E Fecci, John Sampson, Michael Gunn	Journal of Clinical Investigation	2020
Advances in Immunotherapy Delivery from Implantable and Injectable Biomaterials DG Leach, S Young, JD Hartgerink	Acta Biomaterialia	2019
Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment. Zeng Y, Li B, Liang Y, Reeves PM, Qu X, Ran C, Liu Q, Callahan MV, Sluder AE, Gelfand JA, Chen H, Poznansky MC	The FASEB Journal	2019
Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro. Tang M, Liu Y, Zhang QC, Zhang P, Wu JK, Wang JN, Ruan Y, Huang Y	Oncology Letters	2018
Cancer vaccine strategies: translation from mice to human clinical trials JA Berzofsky, M Terabe, JB Trepel, I Pastan, DF Stroncek, JC Morris, LV Wood	Cancer Immunology, Immunotherapy	2017
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy RF Medrano, A Hunger, SA Mendonça, JA Barbuto, BE Strauss	Oncotarget	2017
Advances in Immunotherapy for Glioblastoma Multiforme. Huang B, Zhang H, Gu L, Ye B, Jian Z, Stary C, Xiong X	Journal of Immunology Research	2017
Multifunctional nanoparticles for cancer immunotherapy T Saleh, SA Shojaosadati	Human Vaccines & Immunotherapeutics	2016
Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results. Pham PV, Le HT, Vu BT, Pham VQ, Le PM, Phan NL, Trinh NV, Nguyen HT, Nguyen ST, Nguyen TL, Phan NK	OncoTargets and therapy	2016
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response. Thalmensi J, Pliquet E, Liard C, Escande M, Bestetti T, Julithe M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Loustau M, Caumartin J, Lachgar A, Huet T, Wain-Hobson S, Langlade-Demoyen P	OncoImmunology	2015
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B, Lv L, Wang Z, Jiang Y, Lv W, Liu X, Wang Z, Zhao Y, Xin H, Xu Q	Scientific Reports	2015
Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets. Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JA	Frontiers in immunology	2015
The dichotomy of pathogens and allergens in vaccination approaches FJ Baird, AL Lopata	Frontiers in microbiology	2014
Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction M Rizzo, J Bayo, F Piccioni, M Malvicini, E Fiore, E Peixoto, MG García, JB Aquino, AG Campaña, G Podestá, M Terres, O Andriani, L Alaniz, G Mazzolini, S Nataf	PloS one	2014
Ephs and Ephrins in malignant gliomas. Ferluga S, Debinski W	Growth factors (Chur, Switzerland)	2014
Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE YH Huang, M Terabe, CD Pendleton, DS Khursigara, TK Bera, I Pastan, JA Berzofsky	PloS one	2013
Adoptive cell therapies for glioblastoma K Bielamowicz, S Khawja, N Ahmed	Frontiers in Oncology	2013
Is cancer gene therapy an empty suit? MK Brenner, S Gottschalk, AM Leen, JF Vera	The Lancet Oncology	2013
Early immunisation with dendritic cells after allogeneic bone marrow transplantation elicits graft vs tumour reactivity. Gigi V, Stein J, Askenasy N, Yaniv I, Ash S	British Journal of Cancer	2013
Strategies to Use Immune Modulators in Therapeutic Vaccines Against Cancer JA Berzofsky, M Terabe, LV Wood	Seminars in Oncology	2012
Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Prado-Garcia H, Romero-Garcia S, Aguilar-Cazares D, Meneses-Flores M, Lopez-Gonzalez JS	Clinical & developmental immunology	2012
A composite MyD88/CD40 “switch” synergistically activates mouse and human dendritic cells for enhanced anti-tumor efficacy Priyadharshini Narayanan, Natalia Lapteva, Mamatha Seethammagari, Jonathan Levitt, Kevin Slawin, David Spencer	Journal of Clinical Investigation	2011
Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generation Q Wang, HA Franks, J Porte, ME Refaee, S Shah, J Crooks, PM Patel, AM Jackson	Immunology	2011
In vivo modulation of dendritic cells by engineered materials: Towards new cancer vaccines J Kim, DJ Mooney	Nano Today	2011
Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases J Puskas, D Skrombolas, A Sedlacek, E Lord, M Sullivan, J Frelinger	Immunology	2011
Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice Chen Y, Xie Y, Chan T, Sami A, Ahmed S, Liu Q, Xiang J	Cancer Gene Therapy	2011
Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus. Gong HX, He L, Li XP, Wang YD, Li Y, Huang JJ, Wang Z, Xie D, Kung HF, Peng Y	Oncology reports	2011
Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models H Nakashima, T Fujisawa, SR Husain, RK Puri	Journal of Translational Medicine	2010
Optimal epitope composition after antigen screening using a live bacterial delivery vector: Application to TRP-2 M Derouazi, Y Wang, R Marlu, O Epaulard, JF Mayol, N Pasqual, AL Gouellec, B Polack, B Toussaint	Bioengineered bugs	2010
A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo P Williams, M Rafei, M Bouchentouf, J Raven, S Yuan, J Cuerquis, KA Forner, E Birman, J Galipeau	Molecular Therapy	2010
IMMUNOCAT-a data management system for epitope mapping studies. Chung JL, Sun J, Sidney J, Sette A, Peters B	Journal of biomedicine & biotechnology	2010
Immunotherapy of childhood cancer: from biologic understanding to clinical application. Wayne AS, Capitini CM, Mackall CL	Current Opinion in Pediatrics	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
The effects of DNA formulation and administration route on cancer therapeutic efficacy with xenogenic EGFR DNA vaccine in a lung cancer animal model MD Lai, MC Yen, CM Lin, CF Tu, CC Wang, PS Lin, HJ Yang, CC Lin	Genetic vaccines and therapy	2009
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy M Wang, L Sun, J Qian, X Han, L Zhang, P Lin, Z Cai, Q Yi	Leukemia	2009
Immunotherapy for liver tumors: present status and future prospects P Matar, L Alaniz, V Rozados, JB Aquino, M Malvicini, C Atorrasagasti, M Gidekel, M Silva, OG Scharovsky, G Mazzolini	Journal of Biomedical Science	2009
Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer W Shi, Q Tang, X Chen, P Cheng, P Jiang, X Jing, X Chen, P Chen, Y Wang, Y Wei, Y Wen	Journal of Molecular Medicine	2009
Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRαβ+ CD8αβ + T cells in the small intestinal mucosa D Isakov, A Dzutsev, IM Belyakov, JA Berzofsky	Mucosal Immunology	2009
DNA plasmid production in different host strains of Escherichia coli. Singer A, Eiteman MA, Altman E	Journal of Industrial Microbiology & Biotechnology	2009
Peptide epitope identification for tumor-reactive CD4 T cells H Kobayashi, E Celis	Current Opinion in Immunology	2008
Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization IM Belyakov, JD Ahlers, GJ Nabel, B Moss, JA Berzofsky	Virology	2008
Enhancement of immunotherapeutic effects of HPV16E7 on cervical cancer by fusion with CTLA4 extracellular region Y Zheng, Y Zhang, Y Ma, J Wan, C Shi, L Huang	The Journal of Microbiology	2008
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy S Kim, G Buchlis, ZG Fridlender, J Sun, V Kapoor, G Cheng, A Haas, HK Cheung, X Zhang, M Corbley, LR Kaiser, L Ling, SM Albelda	Cancer research	2008
NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy JQ Gao, Y Tsuda, M Han, DH Xu, N Kanagawa, Y Hatanaka, Y Tani, H Mizuguchi, Y Tsutsumi, T Mayumi, N Okada, S Nakagawa	Cancer Immunology, Immunotherapy	2008
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations Aptsiauri N, Carretero R, Garcia-Lora A, Real LM, Cabrera T, Garrido F	Cancer Immunology, Immunotherapy	2008
Immune cell recruitment and cell-based system for cancer therapy JQ Gao, N Okada, T Mayumi, S Nakagawa	Pharmaceutical Research	2007
Inhibition of Lewis Lung Carcinoma Growth by Toxoplasma gondii through Induction of Th1 Immune Responses and Inhibition of Angiogenesis Kim JO, Jung SS, Kim SY, Kim TY, Shin DW, Lee JH, Lee YH	Journal of Korean Medical Science	2007
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes. Voltan R, Castaldello A, Brocca-Cofano E, Altavilla G, Caputo A, Laus M, Sparnacci K, Ensoli B, Spaccasassi S, Ballestri M, Tondelli L	Pharmaceutical Research	2007
Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease Gu T, Kilinc MO, Egilmez NK	Cancer Immunology, Immunotherapy	2007
Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice HK Kang, YJ Chung, CU Park, YS Jang, BS Kim	Immunology	2006
Overlapping synthetic peptides as vaccines Jiang S, Song R, Popov S, Mirshahidi S, Ruprecht RM	Vaccine	2006
Identification of an immunogenic CD8+ T-cell epitope derived from γ-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia Hirano N, Butler MO, Xia Z, Berezovskaya A, Murray AP, Ansén S, Kojima S, Nadler LM	Blood	2006
Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses Lim SY, Meyer M, Kjonaas RA, Ghosh SK	Journal of immune based therapies and vaccines	2006
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G	Cancer Immunology, Immunotherapy	2006
Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives R Baccala, R Gonzalez-Quintial, W Dummer, AN Theofilopoulos	Springer Seminars in Immunopathology	2005
Mature dendritic cells differentiated in the presence of interferon-b and interleukin-3 prime functional antigen-specific CD8 + T cells J Renneson, M Salio, N Mazouz, M Goldman, A Marchant, V Cerundolo	Clinical & Experimental Immunology	2005
DNA vaccines for cancer too M Yu, OJ Finn	Cancer Immunology, Immunotherapy	2005
In vitro Induction of Myeloid Leukemia–Specific CD4 and CD8 T Cells by CD40 Ligand – Activated B Cells Gene Modified to Express Primary Granule Proteins H Fujiwara, JJ Melenhorst, FE Ouriaghli, S Kajigaya, M Grube, G Sconocchia, K Rezvani, DA Price, NF Hensel, DC Douek, AJ Barrett	Clinical cancer research	2005
Vaccination with a Sindbis Virus-Based DNA Vaccine Expressing Antigen 85B Induces Protective Immunity against Mycobacterium tuberculosis Derrick SC, Yang AL, Morris SL	Infection and immunity	2005
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme Schwartzbaum J, Ahlbom A, Malmer B, Lönn S, Brookes AJ, Doss H, Debinski W, Henriksson R, Feychting M	Cancer research	2005
Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer Cui Z, Huang L	Cancer Immunology, Immunotherapy	2005
A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients Trakatelli M, Toungouz M, Blocklet D, Dodoo Y, Gordower L, Laporte M, Vereecken P, Sales F, Mortier L, Mazouz N, Lambermont M, Goldman S, Coulie P, Goldman M, Velu T	Cancer Immunology, Immunotherapy	2005
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice Johnston D, Reynolds SR, Bystryn JC	Cancer Immunology, Immunotherapy	2005
Progress on new vaccine strategies against chronic viral infections JA Berzofsky, JD Ahlers, J Janik, J Morris, SK Oh, M Terabe, IM Belyakov	Journal of Clinical Investigation	2004
A phase I/II trial of oxidized autologous tumor vaccines during the “watch and wait” phase of chronic lymphocytic leukemia DE Spaner, C Hammond, J Mena, C Foden, A Deabreu	Cancer Immunology, Immunotherapy	2004

Advertisement